These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29749584)

  • 21. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
    Chen BF
    World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
    Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
    World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next generation digital PCR measurement of hepatitis B virus copy number in formalin-fixed paraffin-embedded hepatocellular carcinoma tissue.
    Huang JT; Liu YJ; Wang J; Xu ZG; Yang Y; Shen F; Liu XH; Zhou X; Liu SM
    Clin Chem; 2015 Jan; 61(1):290-6. PubMed ID: 25361948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.
    Kao JH; Liu CJ; Jow GM; Chen PJ; Chen DS; Chen BF
    Liver Int; 2012 Oct; 32(9):1373-81. PubMed ID: 22676233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
    Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP
    J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma.
    Wang M; Qiu N; Lu S; Xiu D; Yu J; Wang XT; Lu F; Li T; Liu X; Zhuang H
    J Med Virol; 2013 Feb; 85(2):219-27. PubMed ID: 23168998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico.
    Lino-Silva LS; Lajous M; Brochier M; Santiago-Ruiz L; Melchor-Ruan J; Xie Y; Wang M; Wu D; Higson H; Jones K; Romero-Martínez M; Villalpando S; Mohar A; Smith JW; Alvarez CS; McGlynn KA; Dean M; Groopman J
    Salud Publica Mex; 2022 Feb; 64(1):35-40. PubMed ID: 35438902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
    Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
    World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic changes in primary liver cancer in Russia: a pilot study.
    Kalinina O; Marchio A; Urbanskii AI; Tarkova AB; Rebbani K; Granov DA; Dejean A; Generalov MI; Pineau P
    Mutat Res; 2013 Aug; 755(2):90-9. PubMed ID: 23830926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC.
    Jiao F; Long L; Ding S; Xie X; Jia L; Lu F
    Microb Pathog; 2017 Aug; 109():49-55. PubMed ID: 28478205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
    Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
    J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and prognosis of hepatocellular carcinoma with respect to pre-S deletion and basal core promoter mutations of hepatitis B virus Genotype C2.
    Ryu HJ; Kim DY; Park JY; Chang HY; Lee MH; Han KH; Chon CY; Ahn SH
    J Med Virol; 2011 Dec; 83(12):2088-95. PubMed ID: 22012715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.